文献速递垂体与肾上腺疾病

单侧原发性醛固酮增多症患者循环miR-222-3p高表达的意义

The Significance of High Expression of Circulating miR-222-3p in Patients With Unilateral Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究比较单侧原发性醛固酮增多症(UPA)与双侧肾上腺增生(BHA)患者循环miRNA谱,发现miR-222-3p在UPA患者肾上腺静脉及下腔静脉中表达显著升高,且与肿瘤直径及盐水输注试验后血浆醛固酮浓度正相关,提示其可作为PA亚型诊断的生化标志物并参与发病机制。

要点

  • 循环miR-222-3p在UPA中表达显著高于BHA,有助亚型鉴别。
  • UPA患者肿瘤侧肾上腺静脉miR-222-3p高于非肿瘤侧。
  • miR-222-3p mimics促进肾上腺细胞增殖,抑制剂则抑制增殖。

核心结论

  • 循环miR-222-3p在UPA中表达高于BHA,为PA亚型诊断提供生化标志物。
  • miR-222-3p与肾上腺细胞增殖及醛固酮分泌相关,提示参与PA发病机制。

研究设计与样本

  • 先以小样本匹配背景因素进行循环miRNA定量PCR panel表达分析,后扩大样本验证候选miRNA。
  • 比较UPA与BHA患者循环miRNA谱,并在UPA患者中比较肿瘤侧与非肿瘤侧肾上腺静脉表达。
  • 体外原代培养肾上腺细胞中转染miR-222-3p mimics或 inhibitors 观察CYP11B2表达与细胞增殖。

主要发现

  • miR-222-3p在UPA患者肾上腺静脉及下腔静脉中表达均显著高于BHA。
  • 同一UPA患者肿瘤侧肾上腺静脉miR-222-3p显著高于非肿瘤侧。
  • miR-222-3p mimics使原代培养肾上腺细胞CYP11B2表达有升高趋势但无统计学显著性。
  • miR-222-3p mimics显著增加细胞增殖,inhibitors显著减少细胞增殖。
  • miR-222-3p表达与肿瘤直径及盐水输注试验后血浆醛固酮浓度呈显著正相关。

关键数值与推荐

  • CDKN1B被鉴定为miR-222-3p的预测靶基因。
  • miR-222-3p mimics对CYP11B2表达的影响无统计学显著性。

临床怎么用

  • 循环miR-222-3p或可作为区分UPA与BHA的候选生化标志物。
  • 其与肿瘤直径及醛固酮浓度的正相关提示可用于PA病情评估。

局限性

  • miR-222-3p mimics对CYP11B2表达的影响未达统计学显著性。
  • CDKN1B仅为预测靶基因,未提供实验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The significance of circulating microRNAs (miRNAs) in primary aldosteronism (PA) is still largely unknown. OBJECTIVE: We compared the profiles of circulating miRNAs between unilateral primary aldosteronism (UPA) and bilateral hyperaldosteronism (BHA) and investigated the potential role of a newly identified UPA-related miRNA in the pathogenesis of PA. METHODS: We initially conducted a comprehensive expression analysis of circulating miRNAs using a quantitative polymerase chain reaction panel in a small number of cases matched for background factors, followed by validation analysis with a larger sample size for the candidate miRNAs. RESULTS: The expression level of one single miRNA, miR-222-3p, was significantly higher in UPA than in BHA, both in the adrenal veins and the inferior vena cava. Moreover, it was significantly higher in the adrenal vein on the tumor side compared to the nontumor side within the same UPA patients. In primary cultured adrenal cells, miR-222-3p mimics appeared to increase CYP11B2 expression, although the effect was not statistically significant. However, transfection with miR-222-3p mimics significantly increased cell proliferation, whereas transfection with miR-222-3p inhibitors decreased it. CDKN1B was identified as a predicted target gene of miR-222-3p. Additionally, the expression level of miR-222-3p exhibited a significant positive correlation with tumor diameter and plasma aldosterone concentration after saline infusion test. CONCLUSION: The present results demonstrated higher expression of circulating miR-222-3p in UPA than in BHA, providing a biochemical marker for subtype diagnosis of PA. Moreover, the correlation of miR-222-3p with adrenal cell proliferation and aldosterone secretion indicated its significant involvement in the pathogenesis of PA.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Okamoto K, Sone M, Taura D, et al. The Significance of High Expression of Circulating miR-222-3p in Patients With Unilateral Primary Aldosteronism. J Clin Endocrinol Metab. 2026. PMID: 40679395. doi:10.1210/clinem/dgaf408

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。